Represented Various Trade Creditors, Secured Creditors, Equipment Lessors, and Contract Counter-parties in Chapter 9 and 11 Cases of Hospitals, Laboratories, Pharmaceutical Companies, and Medical Groups

Represented various trade creditors, secured creditors, equipment lessors, and contract counterparties in Chapter 9 and 11 cases of hospitals, laboratories, pharmaceutical companies, and medical groups, including In re Thomas Health System, Inc. (Bankr. S.D.W.V. 2020) (hospital system); In re Purdue Pharma L.P. (Banrk. S.D.N.Y. 2019) (pharmaceuticals); In re Insys Therapeutics, Inc. (Bankr. D. Del. 2019) (pharmaceuticals); In re Calais Regional Hospital (Bankr. D. Me. 2019); In re Mercy Diagnostics, Inc.(Bankr. W.D.N.C. 2019) (laboratory); In re Verity Health Systems, Inc., et al. (Bankr. C.D. Cal. 2018) (health care system); In re Campbellton-Graceville Hospital Corp. (Bankr. N.D. Fla. 2017) (hospital); In re Little River Healthcare Holdings, LLC, et al. (Bankr. W.D. Tex. 2018) (hospitals and medical groups); In re Surprise Valley Health Care District (Bankr. E.D. Cal. 2018) (health care district); In re Southern Inyo Healthcare District (Bankr. E.D. Cal. 2016) (health care district); In re Institute of Cardiovascular Excellence, PLLC, et al. (Bankr. M.D. Fla. 2016) (medical group); and In re Health Diagnostic Laboratory, Inc., et al. (Bankr. E.D. Va. 2015) (laboratory).